what dose is microdosing semaglutide People are 'microdosing' weight-loss drugs. A GP explains to watch out for | SBS News Is 'Microdosing' Ozempic Safe?

Ongoing pharmacovigilance continues to monitor for any unexpected effects

The most prevalent gastrointestinal adverse effects include: Nausea (37-43% of patients, the most common side effect) Diarrhea (24-30% of patients) Vomiting (19-25% of patients) Constipation (17-24% of patients) Abdominal pain (11-20% of patients) Dyspepsia or indigestion (10-11% of patients) Decreased appetite (reported as a separate effect) It's important to note that while some patients experience increased bowel movements or diarrhea, others develop constipationhighlighting the variable nature of tirzepatide's effects on individual digestive systems

However, there is still a need for further research regarding SFN and the development of a standard dose

Where Retatrutide Stands in Clinical Development Retatrutide has not completed FDA review and holds no marketing authorization

Learn more about what happens when you stop GLP-1s